Sentiment-Signal
16,1
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (20.02.2026)
HOCH Abgang Schlüsselpersonen (20.02.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 20.02.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Co |
| 17.11.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Co |
| 04.03.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 25.01.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Co |
Stammdaten
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries: healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
Unternehmen & Branche
| Name | Ventas, Inc. |
|---|---|
| Ticker | VTR |
| CIK | 0000740260 |
| Boerse | US |
| Sektor | Real Estate |
| Industrie | REIT - Healthcare Facilities |
| SIC | 6798 · Real Estate Investment Trusts |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | REIT |
| Marktkapitalisierung | 41,44 Mrd. USD |
| Beta | 0,77 |
| Dividendenrendite | 1,96 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 5,833,980,000 | 0.54 | 27,591,945,000 | 12,527,253,000 | |
| 2025-09-30 | 10-Q | 1,488,996,000 | 0.14 | 26,925,704,000 | 12,361,924,000 | |
| 2025-06-30 | 10-Q | 1,420,893,000 | 0.15 | 26,474,929,000 | 11,529,388,000 | |
| 2025-03-31 | 10-Q | 1,358,074,000 | 0.10 | 26,032,295,000 | 11,469,557,000 | |
| 2024-12-31 | 10-K | 4,924,266,000 | 0.19 | 26,186,906,000 | 10,771,267,000 | |
| 2024-09-30 | 10-Q | 1,236,315,000 | 0.05 | 25,347,189,000 | 9,759,094,000 | |
| 2024-06-30 | 10-Q | 1,200,980,000 | 0.05 | 24,530,229,000 | 9,619,350,000 | |
| 2024-03-31 | 10-Q | 1,199,914,000 | -0.04 | 24,672,586,000 | 9,402,840,000 | |
| 2023-12-31 | 10-K | 4,497,827,000 | -0.10 | 24,725,433,000 | 9,488,058,000 | |
| 2023-09-30 | 10-Q | 1,149,832,000 | -0.18 | 24,966,609,000 | 9,817,559,000 | |
| 2023-06-30 | 10-Q | 1,106,358,000 | 0.26 | 25,070,862,000 | 9,968,382,000 | |
| 2023-03-31 | 10-Q | 1,077,245,000 | 0.04 | 23,994,168,000 | 9,996,991,000 | |
| 2022-12-31 | 10-K | 4,129,193,000 | -0.12 | 24,157,840,000 | 10,152,968,000 | |
| 2022-09-30 | 10-Q | 1,037,276,000 | 0.00 | 24,300,411,000 | 10,361,359,000 | |
| 2022-06-30 | 10-Q | 1,022,938,000 | -0.11 | 24,628,155,000 | 10,512,596,000 | |
| 2022-03-31 | 10-Q | 1,017,554,000 | 0.10 | 24,950,107,000 | 10,697,406,000 | |
| 2021-12-31 | 10-K | 3,828,007,000 | 0.13 | 24,717,786,000 | 10,854,385,000 | |
| 2021-09-30 | 10-Q | 976,078,000 | 0.16 | 25,044,424,000 | 11,076,716,000 | |
| 2021-06-30 | 10-Q | 919,194,000 | 0.23 | 23,504,314,000 | 9,882,699,000 | |
| 2021-03-31 | 10-Q | 910,291,000 | -0.15 | 23,552,263,000 | 9,970,155,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-02-11 | Roberts Carey S. | Officer, EVP and GC | Open Market Sale | -35,532 | 85.00 | -3,020,116.96 | -165,9% | |
| 2026-02-06 | CAFARO DEBRA A | Director, Officer, Chairman and CEO | Open Market Sale | -10,322 | 82.23 | -848,751.22 | -46,6% | |
| 2026-02-02 | CAFARO DEBRA A | Director, Officer, Chairman and CEO | Open Market Sale | -10,322 | 77.66 | -801,605.49 | -44,0% | |
| 2026-01-02 | Probst Robert F | Officer, EVP and CFO | Open Market Sale | -29,930 | 77.25 | -2,312,188.28 | -127,0% | |
| 2026-01-02 | CAFARO DEBRA A | Director, Officer, Chairman and CEO | Open Market Sale | -10,322 | 77.26 | -797,474.62 | -43,8% | |
| 2025-12-01 | CAFARO DEBRA A | Director, Officer, Chairman and CEO | Open Market Sale | -10,322 | 80.55 | -831,418.52 | -45,7% | |
| 2025-11-19 | Bulgarelli Peter J. | Officer, EVP OM&R-Ventas/Pres&CEO-LHS | Open Market Sale | -2,229 | 80.08 | -178,504.34 | -9,8% | |
| 2025-11-18 | Bulgarelli Peter J. | Officer, EVP OM&R-Ventas/Pres&CEO-LHS | Open Market Sale | -2,771 | 80.01 | -221,700.51 | -12,2% | |
| 2025-11-17 | CAFARO DEBRA A | Director, Officer, Chairman and CEO | Open Market Sale | -41,294 | 79.01 | -3,262,535.71 | -179,2% | |
| 2025-11-12 | Probst Robert F | Officer, EVP and CFO | Open Market Sale | -33,591 | 76.77 | -2,578,844.89 | -141,7% | |
| 2025-11-07 | Bulgarelli Peter J. | Officer, EVP OM&R-Ventas/Pres&CEO-LHS | Open Market Sale | -40 | 75.70 | -3,028.05 | -0,2% | |
| 2025-11-06 | Bulgarelli Peter J. | Officer, EVP OM&R-Ventas/Pres&CEO-LHS | Open Market Sale | -166 | 75.15 | -12,475.48 | -0,7% | |
| 2025-11-06 | CAFARO DEBRA A | Director, Officer, Chairman and CEO | Open Market Sale | -264 | 75.05 | -19,812.91 | -1,1% | |
| 2025-11-05 | Bulgarelli Peter J. | Officer, EVP OM&R-Ventas/Pres&CEO-LHS | Open Market Sale | -870 | 75.28 | -65,493.95 | -3,6% | |
| 2025-11-05 | CAFARO DEBRA A | Director, Officer, Chairman and CEO | Open Market Sale | -19,250 | 75.29 | -1,449,347.90 | -79,6% | |
| 2025-11-04 | CAFARO DEBRA A | Director, Officer, Chairman and CEO | Open Market Sale | -11,452 | 75.02 | -859,147.36 | -47,2% | |
| 2025-11-04 | Bulgarelli Peter J. | Officer, EVP OM&R-Ventas/Pres&CEO-LHS | Open Market Sale | -3,924 | 75.00 | -294,286.66 | -16,2% | |
| 2025-11-03 | CAFARO DEBRA A | Director, Officer, Chairman and CEO | Open Market Sale | -10,322 | 73.98 | -763,594.72 | -41,9% | |
| 2025-11-03 | CAFARO DEBRA A | Director, Officer, Chairman and CEO | Open Market Sale | -10,322 | 73.74 | -761,095.77 | -41,8% | |
| 2025-10-30 | CAFARO DEBRA A | Director, Officer, Chairman and CEO | Open Market Sale | -20,644 | 74.34 | -1,534,720.38 | -84,3% | |
| 2025-10-30 | CAFARO DEBRA A | Director, Officer, Chairman and CEO | Open Market Sale | -224,360 | 74.34 | -16,678,383.94 | -916,2% | |
| 2025-10-30 | CAFARO DEBRA A | Director, Officer, Chairman and CEO | Open Market Sale | -41,288 | 73.64 | -3,040,345.10 | -167,0% | |
| 2025-10-30 | CAFARO DEBRA A | Director, Officer, Chairman and CEO | Open Market Sale | -30,966 | 74.32 | -2,301,318.80 | -126,4% | |
| 2025-10-20 | CAFARO DEBRA A | Director, Officer, Chairman and CEO | Open Market Sale | -185,283 | 71.32 | -13,214,883.82 | -725,9% | |
| 2025-10-20 | CAFARO DEBRA A | Director, Officer, Chairman and CEO | Open Market Sale | -34,232 | 71.32 | -2,441,518.67 | -134,1% | |
| 2025-10-01 | Bulgarelli Peter J. | Officer, EVP OM&R-Ventas/Pres&CEO-LHS | Open Market Sale | -2,554 | 70.26 | -179,435.36 | -9,9% | |
| 2025-10-01 | CAFARO DEBRA A | Director, Officer, Chairman and CEO | Open Market Sale | -10,322 | 70.24 | -724,986.31 | -39,8% | |
| 2025-09-30 | Bulgarelli Peter J. | Officer, EVP OM&R-Ventas/Pres&CEO-LHS | Open Market Sale | -2,040 | 69.99 | -142,779.60 | -7,8% | |
| 2025-09-15 | Bulgarelli Peter J. | Officer, EVP OM&R-Ventas/Pres&CEO-LHS | Open Market Sale | -406 | 70.00 | -28,418.94 | -1,6% | |
| 2025-09-02 | CAFARO DEBRA A | Director, Officer, Chairman and CEO | Open Market Sale | -10,322 | 67.80 | -699,863.60 | -38,4% | |
| 2025-08-04 | Probst Robert F | Officer, EVP and CFO | Open Market Sale | -29,691 | 68.49 | -2,033,587.06 | -111,7% | |
| 2025-08-01 | CAFARO DEBRA A | Director, Officer, Chairman and CEO | Open Market Sale | -10,322 | 67.40 | -695,722.41 | -38,2% | |
| 2025-07-31 | Probst Robert F | Officer, EVP and CFO | Open Market Sale | -3,900 | 68.45 | -266,960.07 | -14,7% | |
| 2025-07-21 | Probst Robert F | Officer, EVP and CFO | Open Market Sale | -29,493 | 66.29 | -1,954,949.40 | -107,4% | |
| 2025-07-18 | CAFARO DEBRA A | Director, Officer, Chairman and CEO | Open Market Sale | -4,375 | 65.82 | -287,976.50 | -15,8% | |
| 2025-07-18 | Probst Robert F | Officer, EVP and CFO | Open Market Sale | -4,098 | 66.24 | -271,454.39 | -14,9% | |
| 2025-07-16 | CAFARO DEBRA A | Director, Officer, Chairman and CEO | Open Market Sale | -1,224 | 65.62 | -80,320.23 | -4,4% | |
| 2025-07-15 | CAFARO DEBRA A | Director, Officer, Chairman and CEO | Open Market Sale | -292 | 65.65 | -19,168.72 | -1,1% | |
| 2025-07-14 | CAFARO DEBRA A | Director, Officer, Chairman and CEO | Open Market Sale | -14,753 | 65.60 | -967,821.88 | -53,2% | |
| 2025-07-14 | Probst Robert F | Officer, EVP and CFO | Open Market Sale | -168,318 | 65.36 | -11,000,742.69 | -604,3% | |
| 2025-05-30 | Roberts Carey S. | Officer, EVP and GC | Open Market Sale | -23,500 | 64.23 | -1,509,447.30 | -82,9% | |
| 2025-05-27 | Probst Robert F | Officer, EVP and CFO | Open Market Sale | -17,374 | 65.22 | -1,133,139.23 | -62,2% | |
| 2025-05-21 | Probst Robert F | Officer, EVP and CFO | Open Market Sale | -33,592 | 64.57 | -2,169,022.00 | -119,1% | |
| 2025-05-21 | Probst Robert F | Officer, EVP and CFO | Open Market Sale | -36,000 | 64.62 | -2,326,190.40 | -127,8% | |
| 2025-05-14 | RAKOWICH WALTER C | Director | Open Market Sale | -1,459 | 63.76 | -93,025.69 | -5,1% | |
| 2025-05-02 | CAFARO DEBRA A | Director, Officer, Chairman and CEO | Open Market Sale | -1,212 | 66.45 | -80,531.95 | -4,4% | |
| 2025-05-01 | CAFARO DEBRA A | Director, Officer, Chairman and CEO | Open Market Sale | -9,110 | 66.04 | -601,603.45 | -33,0% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.